AIM
Income statement / Annual
Last year (2024), AIM ImmunoTech Inc.'s total revenue was $170.00 K,
a decrease of 15.84% from the previous year.
In 2024, AIM ImmunoTech Inc.'s net income was -$17.32 M.
See AIM ImmunoTech Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
| Period Ended |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
| Operating Revenue |
$170.00 K |
$202.00 K |
$141.00 K |
$135.00 K |
$163.00 K |
$140.00 K |
$367.00 K |
$437.00 K |
$92.00 K |
$133.00 K |
| Cost of Revenue |
$31.00 K
|
$42.00 K
|
-$424.00 K
|
$850.00 K
|
$806.00 K
|
$893.00 K
|
$884.00 K
|
$1.18 M
|
$1.11 M
|
$1.60 M
|
| Gross Profit |
$139.00 K
|
$160.00 K
|
$565.00 K
|
-$715.00 K
|
-$643.00 K
|
-$753.00 K
|
-$517.00 K
|
-$746.00 K
|
-$1.02 M
|
-$1.47 M
|
| Gross Profit Ratio |
0.82
|
0.79
|
4.01
|
-5.3
|
-3.94
|
-5.38
|
-1.41
|
-1.71
|
-11.04
|
-11.02
|
| Research and Development Expenses |
$6.20 M
|
$10.93 M
|
$6.99 M
|
$7.67 M
|
$5.72 M
|
$4.65 M
|
$4.78 M
|
$4.10 M
|
$5.11 M
|
$8.04 M
|
| General & Administrative Expenses |
$13.71 M
|
$21.14 M
|
$0.00
|
$8.67 M
|
$8.65 M
|
$7.04 M
|
$6.20 M
|
$6.57 M
|
$7.68 M
|
$7.15 M
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$13.71 M
|
$21.14 M
|
$13.50 M
|
$8.67 M
|
$8.65 M
|
$7.04 M
|
$6.20 M
|
$6.57 M
|
$7.68 M
|
$7.15 M
|
| Other Expenses |
$0.00
|
$0.00
|
$0.00
|
$1.78 M
|
$135.00 K
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Operating Expenses |
$19.91 M
|
$32.08 M
|
$20.49 M
|
$18.12 M
|
$14.51 M
|
$11.69 M
|
$10.98 M
|
$10.67 M
|
$12.79 M
|
$15.19 M
|
| Cost And Expenses |
$19.94 M
|
$32.12 M
|
$20.06 M
|
$18.97 M
|
$15.32 M
|
$12.58 M
|
$11.86 M
|
$11.85 M
|
$13.90 M
|
$16.78 M
|
| Interest Income |
$5.19 M
|
$0.00
|
$629.00 K
|
$0.00
|
$219.00 K
|
$89.00 K
|
$32.00 K
|
$88.00 K
|
$129.00 K
|
$364.00 K
|
| Interest Expense |
$585.00 K
|
$0.00
|
$0.00
|
$67.00 K
|
$672.00 K
|
$427.00 K
|
$502.00 K
|
$139.00 K
|
$0.00
|
$3.00 K
|
| Depreciation & Amortization |
$246.00 K
|
$238.00 K
|
-$424.00 K
|
$775.00 K
|
$733.00 K
|
$829.00 K
|
$920.00 K
|
$1.00 M
|
$1.17 M
|
$1.19 M
|
| EBITDA |
-$16.49 M |
-$28.72 M |
-$19.87 M |
-$18.29 M |
-$13.00 M |
-$8.15 M |
-$8.41 M |
-$7.12 M |
-$6.33 M |
-$14.25 M |
| EBITDA Ratio |
-96.99
|
-142.2
|
-140.91
|
-135.44
|
-79.72
|
-58.2
|
-22.9
|
-16.28
|
-68.84
|
-107.16
|
| Operating Income Ratio |
-116.31
|
-158
|
-141.3
|
-139.54
|
-92.96
|
-88.88
|
-31.32
|
-26.12
|
-150.04
|
-125.19
|
| Total Other Income/Expenses Net |
$2.45 M
|
$2.95 M
|
$477.81 K
|
-$289.00 K
|
$752.00 K
|
$3.04 M
|
$1.67 M
|
$3.16 M
|
$6.30 M
|
$1.42 M
|
| Income Before Tax |
-$17.32 M
|
-$28.96 M
|
-$19.45 M
|
-$19.13 M
|
-$14.40 M
|
-$9.53 M
|
-$9.81 M
|
-$8.26 M
|
-$7.50 M
|
-$15.23 M
|
| Income Before Tax Ratio |
-101.88
|
-143.38
|
-137.91
|
-141.68
|
-88.34
|
-68.09
|
-26.74
|
-18.9
|
-81.54
|
-114.51
|
| Income Tax Expense |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$1.29 M
|
$2.19 M
|
$0.00
|
$0.00
|
$3.00 K
|
| Net Income |
-$17.32 M
|
-$28.96 M
|
-$19.45 M
|
-$19.13 M
|
-$14.40 M
|
-$10.83 M
|
-$9.81 M
|
-$8.26 M
|
-$7.50 M
|
-$15.23 M
|
| Net Income Ratio |
-101.88
|
-143.38
|
-137.91
|
-141.68
|
-88.34
|
-77.33
|
-26.74
|
-18.9
|
-81.54
|
-114.51
|
| EPS |
-0.31 |
-0.6 |
-0.44 |
-0.45 |
-0.51 |
-2.97 |
-9.77 |
-12.67 |
-15.13 |
-34.05 |
| EPS Diluted |
-0.31 |
-0.6 |
-0.44 |
-0.45 |
-0.51 |
-2.97 |
-9.77 |
-12.67 |
-15.13 |
-34.05 |
| Weighted Average Shares Out |
$560.17 K
|
$485.85 K
|
$480.47 K
|
$473.40 K
|
$318.43 K
|
$36.43 K
|
$10.04 K
|
$6.52 K
|
$4.96 K
|
$4.47 K
|
| Weighted Average Shares Out Diluted |
$560.17 K
|
$485.85 K
|
$480.47 K
|
$473.40 K
|
$318.43 K
|
$36.43 K
|
$10.04 K
|
$6.52 K
|
$4.96 K
|
$4.47 K
|
| Link |
|
|
|
|
|
|
|
|
|
|
